Log In
Print
BCIQ
Print
Print this Print this
 

DMTXinvaScan

  Manage Alerts
Collapse Summary General Information
Company Oncomatrix S.L.
DescriptionImmunohistochemistry kit using a mAb developed by Oncomatrix to detect collagen type XI alpha 1 (COL11A1) gene and its encoded protein
Molecular Target
Mechanism of ActionDiagnostic; Antibody
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose and prognose the invasiveness of tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today